Abstract
The role of gamma interferon (IFN-gamma) in host defense to Pneumocystis carinii was investigated by use of three different murine models of infection. C57BL/6 scid/scid (severe combined immunodeficient [SCID]) mice were given intratracheal inoculations of P. carinii and reconstituted with splenocytes from either mice with disrupted IFN-gamma genes (IFN-gamma-/- mice) or homozygous wild-type (IFN-gamma+/+) mice. Unreconstituted SCID mice had log10 7.08 +/- 0.13 P. carinii nuclei in their lungs at day 22 postinfection, whereas SCID mice reconstituted with splenocytes from either wild-type or IFN-gamma-/- mice had cleared the infection. However, there was a prolonged and exacerbated inflammatory response in the lungs of SCID mice reconstituted with IFN-gamma-/- splenocytes which was characterized by interstitial pneumonia, eosinophilia, and multinucleated giant cell formation. Similar results were found in C.B17 SCID mice reconstituted with CD4+ cells from P. carinii-immunized donors treated with neutralizing anti-IFN-gamma monoclonal antibody (MAb). These mice resolved their P. carinii infections; however, they also exhibited exacerbated lung pathology compared with mice treated with a control MAb. Finally, IFN-gamma-/- mice challenged intratracheally with P. carinii resolved their infection within 56 days as did IFN-gamma+/- mice. Furthermore, depletion of T cells in vivo with a MAb resulted in IFN-gamma-/- mice becoming susceptible to P. carinii infection. Together, these data indicate that IFN-gamma is not required for resolution of P. carinii infection; however, in the absence of IFN-gamma, there is a prolonged and exacerbated P. carinii-driven interstitial pneumonia characterized by eosinophilia and formation of multinucleated giant cells.
MeSH Terms
Animals
Antibodies, Monoclonal/therapeutic use
CD4-Positive T-Lymphocytes/transplantation
Interferon-gamma/immunology,physiology
Lung/microbiology
Lymphocyte Transfusion
Mice
Pneumocystis/immunology
Pneumonia, Pneumocystis/immunology,microbiology,pathology
Spleen/cytology,transplantation
Chemicals
Antibodies, Monoclonal
Interferon-gamma
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Garvy B A
Trudeau Institute, Saranac Lake, New York 12983, USA. bgarvy@northnet.org
Ezekowitz R A
Harmsen A G
References (22)
22 references, click to expand
-
Purification and further characterization of an anti-murine interferon-gamma monoclonal neutralizing antibody.
J Interferon Res. 1986 Oct;6(5):489-97
PMID: 3100664
-
The expanding universe of T-cell subsets: Th1, Th2 and more.
Immunol Today. 1996 Mar;17(3):138-46
PMID: 8820272
-
Interferon-gamma: the major mediator of resistance against Toxoplasma gondii.
Science. 1988 Apr 22;240(4851):516-8
PMID: 3128869
-
Role of alveolar macrophages in lipopolysaccharide-induced neutrophil accumulation.
Infect Immun. 1988 Aug;56(8):1858-63
PMID: 3397176
-
Role in vivo for gamma interferon in control of pneumonia caused by Chlamydia trachomatis in mice.
Infect Immun. 1988 Nov;56(11):3004-6
PMID: 3139569
-
Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells.
J Immunol. 1990 May 1;144(9):3288-95
PMID: 1970350
-
Requirement for CD4+ cells in resistance to Pneumocystis carinii pneumonia in mice.
J Exp Med. 1990 Sep 1;172(3):937-45
PMID: 2117637
-
Enhanced treatment of Pneumocystis carinii pneumonia in rats with interferon-gamma and reduced doses of trimethoprim/sulfamethoxazole.
J Acquir Immune Defic Syndr. 1990;3(10):943-8
PMID: 2118951
-
Interaction of cytokines and alveolar cells with Pneumocystis carinii in vitro.
J Infect Dis. 1991 Mar;163(3):611-6
PMID: 1899874
-
Reduction in intensity of Pneumocystis carinii pneumonia in mice by aerosol administration of gamma interferon.
Infect Immun. 1991 Nov;59(11):3859-62
PMID: 1682252
-
The importance of route of infection in determining the extent of exacerbation of listeriosis by anti-interferon-gamma monoclonal antibody.
J Interferon Res. 1991 Oct;11(5):291-5
PMID: 1774468
-
Importance of endogenous tumor necrosis factor alpha and gamma interferon in host resistance against Pneumocystis carinii infection.
Infect Immun. 1992 Apr;60(4):1279-84
PMID: 1548057
-
Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4+ but not CD8+ T cells into severe combined immunodeficiency mice.
J Clin Invest. 1992 Aug;90(2):673-8
PMID: 1353767
-
Development and resolution of Pneumocystis carinii pneumonia in severe combined immunodeficient mice: a morphological study of host inflammatory responses.
Int J Exp Pathol. 1992 Dec;73(6):709-20
PMID: 1493101
-
Analysis of cellular response and gamma interferon synthesis in bronchoalveolar lavage fluid and lung homogenate of mice infected with Pneumocystis carinii.
Microbiol Immunol. 1995;39(1):49-58
PMID: 7783677
-
Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice.
Infect Immun. 1995 Jul;63(7):2391-5
PMID: 7790048
-
Generation and in vivo persistence of polarized Th1 and Th2 memory cells.
Immunity. 1994 Oct;1(7):543-52
PMID: 7600283
-
CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.
J Immunol. 1995 Oct 1;155(7):3525-9
PMID: 7561048
-
Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.
J Exp Med. 1996 Jan 1;183(1):109-17
PMID: 8551213
-
Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile.
J Immunol. 1996 Apr 15;156(8):2680-5
PMID: 8609383
-
Impaired immunity and altered pulmonary responses in mice with a disrupted interferon-gamma receptor gene exposed to the irradiated Schistosoma mansoni vaccine.
Immunology. 1996 Feb;87(2):275-82
PMID: 8698391
-
Analysis of the developmental stages of Pneumocystis carinii, in vitro.
Lab Invest. 1988 Mar;58(3):324-31
PMID: 3258045